D.E. Shaw & Co
PBH icon

D.E. Shaw & Co’s Prestige Consumer Healthcare PBH Stock Holding History

D.E. Shaw & Co’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-50,000
Closed -$1.79M – 4524
2013
Q4 		$1.79M Sell
50,000
-20,000
-29% -$664K ﹤0.01% 2631
2013
Q3 		$2.11M Buy
70,000
+50,000
+250% +$1.63M ﹤0.01% 2373
2013
Q2 		$583K Buy
+20,000
New +$564K ﹤0.01% 3125

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co's PBH Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Prestige Consumer Healthcare (PBH) stake by 19% in Q1 2026, selling an estimated $5.98M and leaving 381,033 shares worth $22.6M. The position accounts for 0.01% of the portfolio, ranked #1074.

D.E. Shaw & Co first reported a position in PBH in Q3 2013 and has held it in 34 quarters since. The position peaked at $33.6M in Q3 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • D.E. Shaw & Co held 381,033 shares of Prestige Consumer Healthcare worth $22.6M as of Q1 2026.
  • D.E. Shaw & Co sold 92,104 Prestige Consumer Healthcare shares in Q1 2026, an estimated $5.98M.
  • Prestige Consumer Healthcare made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1074 holding.
  • D.E. Shaw & Co first reported a position in Prestige Consumer Healthcare in Q3 2013 and has held it in 34 quarters since.
  • D.E. Shaw & Co's Prestige Consumer Healthcare position peaked at $33.6M in Q3 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.